| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 55.2617 | 60 |
| GSM780708 | Untreated after 4 days (C2_1) | 52.0702 | 54 |
| GSM780709 | Untreated after 4 days (C3_1) | 57.7683 | 63 |
| GSM780719 | Untreated after 4 days (C1_2) | 60.6257 | 65 |
| GSM780720 | Untreated after 4 days (C2_2) | 59.3396 | 64 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.1127 | 54 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 57.1913 | 62 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 54.3941 | 59 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 60.1447 | 65 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 54.8377 | 59 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 64.312 | 67 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 60.9599 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.1955 | 58 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 59.5473 | 64 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 60.4724 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 57.8877 | 63 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.8273 | 62 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 59.5532 | 64 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 66.1996 | 68 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 62.1807 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 60.3352 | 65 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 63.393 | 66 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 59.9341 | 64 |